N-17350

N/A

Report date: 2026/05/15 20:01:45
First In Class

Base Information

Drug NameN-17350
Drug Alias NameN-17350N17350
ClassificationBiologics
Mechanisms of ActionApoptosis stimulantsT lymphocytes stimulants
TargetsUpdating
Therapy Area/IndicationsSolid tumoursCarcinoma, Non-Small-Cell LungSkin Neoplasms +[8
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesOnchilles Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesOnchilles Pharma Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursCarcinoma, Non-Small-Cell LungSkin Neoplasms +[8
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A